Bernard Iung

Q: What Schools Are Affiliated With Bernard Iung

Bernard Iung is affiliated with the following schools: Normandy University Group, Université Paris Cité, Paris Diderot University, University of Rennes 1

Bernard Iung's AcademicInfluence.com Rankings

Bernard Iung

Computer Science

#4540

World Rank

#4790

Historical Rank

Machine Learning

#923

World Rank

#936

Historical Rank

Artificial Intelligence

#1143

World Rank

#1163

Historical Rank

Database

#1753

World Rank

#1838

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Bernard Iung's Degrees

PhD Computer Science Université Paris Cité
Masters Computer Science Université Paris Cité
Bachelors Computer Science Université Paris Cité

Similar Degrees You Can Earn

Why Is Bernard Iung Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernard Iung's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
2017 ESC/EACTS Guidelines for the management of valvular heart disease. (2017) (3799)
Guidelines on the management of valvular heart disease (version 2012). (2012) (3651)
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. (2006) (3572)
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). (2015) (3238)
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. (2003) (3171)
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. (2009) (2183)
[Guidelines on the management of valvular heart disease]. (2013) (1753)
[2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. (2014) (1716)
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). (2011) (1677)
[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017) (1605)
Registry of transcatheter aortic-valve implantation in high-risk patients. (2012) (1207)
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases (2015) (1182)
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. (2013) (1177)
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? (2005) (1134)
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation (2018) (1045)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2018) (1035)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (983)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (880)
[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. (2016) (822)
ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy (2012) (788)
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? (2007) (784)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. (2009) (694)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. (2011) (579)
Epidemiology of valvular heart disease in the adult (2011) (557)
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. (2012) (539)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. (2009) (456)
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. (2010) (442)
Infective endocarditis in Europe: lessons from the Euro heart survey (2003) (431)
Calcific aortic stenosis (2016) (393)
Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. (2009) (388)
[2015 ESC Guidelines for the management of infective endocarditis]. (2015) (376)
2017 ESC/EACTS Guidelines for the management of valvular heart disease. (2017) (374)
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. (2012) (348)
Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction (2010) (343)
Recommendations for the management of patients after heart valve surgery. (2005) (320)
Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. (2009) (306)
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. (2019) (296)
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. (2019) (296)
Epidemiology of acquired valvular heart disease. (2014) (293)
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. (2017) (264)
Recommendations on the management of the asymptomatic patient with valvular heart disease. (2002) (247)
Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. (1999) (245)
MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. (2002) (237)
Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis (2010) (235)
Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. (2005) (228)
Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. (1996) (221)
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. (1996) (212)
Valvular heart disease in the community: a European experience. (2007) (198)
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score (2014) (196)
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. (2013) (195)
Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 Registry (2014) (193)
2015 ESC Guidelines for the management of infective endocarditis. (2016) (193)
The modern epidemiology of heart valve disease (2015) (189)
ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. (2012) (188)
Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. (1999) (182)
Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis (2014) (181)
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? (2011) (168)
TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. (2016) (167)
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. (2019) (166)
Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry (2015) (159)
ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. (2013) (153)
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2022) (138)
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years (2019) (137)
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. (2008) (136)
Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. (2012) (135)
Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. (2010) (135)
Clinical Outcomes and Safety of Transfemoral Aortic Valve Implantation Under General Versus Local Anesthesia: Subanalysis of the French Aortic National CoreValve and Edwards 2 Registry (2014) (125)
Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. (1996) (116)
Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease (2018) (114)
Contemporary results of mitral valve repair for infective endocarditis. (2004) (113)
Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry. (2016) (111)
Assessment of the mitral valve area in patients with mitral stenosis by multislice computed tomography. (2006) (109)
Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality* (2006) (106)
Brief Report: Prevalence of Antineutrophil Cytoplasmic Antibodies in Infective Endocarditis (2014) (105)
Is a planned caesarean section in women with cardiac disease beneficial? (2014) (103)
Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis (2013) (101)
Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry. (2015) (101)
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease (2017) (100)
Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. (2011) (98)
Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: Study From the FRANCE 2 Registry (2013) (97)
Degenerative calcific aortic stenosis: a natural history (2012) (97)
Cerebral Microbleeds Are Frequent in Infective Endocarditis: A Case–Control Study (2009) (96)
Late Results of Percutaneous Mitral Commissurotomy up to 20 Years: Development and Validation of a Risk Score Predicting Late Functional Results From a Series of 912 Patients (2012) (95)
Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. (2020) (88)
Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. (2013) (86)
Temporal trends in percutaneous mitral commissurotomy over a 15-year period. (2004) (85)
Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry. (2019) (84)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) (2014) (83)
Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. (1999) (82)
Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography (2007) (81)
Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. (1994) (80)
Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. (2016) (78)
Corrigendum to: 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. (2015) (77)
Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. (2006) (77)
Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement (2019) (74)
Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry. (2015) (74)
Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry (2018) (74)
Management of the elderly patient with aortic stenosis (2007) (72)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2019) (70)
Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging (2013) (70)
Management of ischaemic mitral regurgitation (2003) (69)
The new ESC/EACTS guidelines on the management of valvular heart disease. (2012) (69)
The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. (2014) (68)
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
Transseptal Transcatheter Mitral Valve Replacement Using Balloon-Expandable Transcatheter Heart Valves: A Step-by-Step Approach. (2017) (67)
Diagnosis of left atrial thrombi in mitral stenosis--usefulness of ultrasound techniques compared with other methods. (1991) (67)
Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. (2000) (66)
Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. (2014) (66)
Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. (2012) (66)
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation. (2014) (65)
Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. (2013) (65)
Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). (2013) (65)
Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience (2018) (64)
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. (2016) (64)
Determinants of Cerebral Lesions in Endocarditis on Systematic Cerebral Magnetic Resonance Imaging: A Prospective Study (2013) (63)
Characterization of 18F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves (2017) (62)
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement. (2019) (61)
Implementation of Transcatheter Aortic Valve Replacement in France. (2018) (61)
Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. (1993) (61)
Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. (2016) (60)
Value of multiplane transesophageal echocardiography in determining aortic valve area in aortic stenosis. (1996) (60)
Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. (2011) (59)
Interface between valve disease and ischaemic heart disease (2000) (57)
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial (2021) (57)
Infective Endocarditis After Transcatheter Aortic Valve ImplantationCLINICAL PERSPECTIVE (2015) (56)
Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. (2014) (55)
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. (2016) (55)
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease. (2018) (54)
Ten-year results of percutaneous mitral commissurotomy in a series of 1024 patients (1998) (53)
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery (2021) (53)
Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. (2000) (53)
Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels. (2003) (52)
Relationship between longitudinal strain and symptomatic status in aortic stenosis. (2013) (52)
Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty (2002) (51)
Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. (2014) (50)
Size-adjusted left ventricular outflow tract diameter reference values: a safeguard for the evaluation of the severity of aortic stenosis. (2009) (50)
Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. (2017) (50)
Long-term outcome after transcatheter aortic valve implantation (2015) (50)
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. (2012) (49)
Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry. (2014) (48)
Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis (2010) (47)
Early hemodynamic changes versus peak values: what is more useful to predict occurrence of dyspnea during stress echocardiography in patients with asymptomatic mitral stenosis? (2011) (45)
Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: late efficacy and implications for patient selection. (2000) (45)
Transcatheter aortic valve implantation: selection strategy is crucial for outcome. (2009) (43)
Early assessment by transesophageal echocardiography of left atrial appendage function after percutaneous mitral commissurotomy. (1996) (43)
Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA–GENERAC study (2013) (43)
Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes: Insights From the FRANCE TAVI Registry. (2018) (41)
Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. (2013) (41)
The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. (2015) (41)
Echocardiographic evaluation of the mitral valve area before and after percutaneous mitral commissurotomy: the pressure half-time method revisited. (2005) (41)
Influence of percutaneous mitral commissurotomy on left atrial spontaneous contrast of mitral stenosis. (1993) (40)
Transcatheter heart valve interventions: where are we? Where are we going? (2019) (40)
Cohort profile The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. (2019) (39)
2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease (2016) (39)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
Cohort profile The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. (2019) (39)
Impact of pre‐ and post‐procedural anemia on the incidence of acute kidney injury and 1‐year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry) (2015) (39)
Percutaneous transvenous mitral commissurotomy using the Inoue balloon: international experience. (1994) (39)
The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation. (1995) (38)
Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After Mitraclip Implantation: Results From the Mitra-FR Trial. (2020) (38)
Impact of chronic obstructive pulmonary disease on Valve Academic Research Consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). (2014) (38)
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study (2018) (38)
Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis (2017) (37)
Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis (2017) (37)
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. (2014) (36)
Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. (1993) (36)
Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. (2017) (36)
Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. (2012) (36)
Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. (2013) (36)
Recommandations de la Société française de cardiologie concernant la prise en charge de l'infarctus du myocarde après la phase aiguë (2001) (36)
Sequential assessment of mitral valve area during diastole using colour M-mode flow convergence analysis: new insights into mitral stenosis physiology. (2003) (35)
Tricuspid valve and percutaneous approach: No longer the forgotten valve! (2016) (35)
Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. (2012) (35)
Diagnostic Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and White Blood Cell SPECT/Computed Tomography in Patients With Suspected Cardiac Implantable Electronic Device Chronic Infection. (2019) (34)
Homograft replacement of the mitral valve: eight-year results. (2004) (33)
Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis (2014) (33)
Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. (2009) (33)
Infective endocarditis: innovations in the management of an old disease (2019) (33)
Multiple and Mixed Valvular Heart Diseases: Pathophysiology, Imaging, and Management (2018) (33)
Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT. (2003) (32)
Transfemoral tricuspid valve-in-ring implantation using the edwards Sapien XT valve: one-year follow-up. (2015) (31)
Management of atrial fibrillation in patients with rheumatic mitral stenosis (2018) (31)
Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry. (2014) (31)
Valvular heart diseases in elderly people (2006) (31)
Evaluation of mitral stenosis in 2008. (2008) (31)
Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes (2002) (30)
Bail-Out Alcohol Septal Ablation for Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. (2016) (30)
Ventricular arrhythmias in aortic valve disease before and after aortic valve replacement. (1992) (29)
Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies (2011) (28)
Usefulness of the right parasternal view and non-imaging continuous-wave Doppler transducer for the evaluation of the severity of aortic stenosis in the modern area. (2009) (27)
Percutaneous mitral commissurotomy in the elderly. (1995) (27)
Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis. (2017) (27)
Long-term clinical outcomes after rescue angioplasty are not different from those of successful thrombolysis for acute myocardial infarction. (2005) (27)
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study (2017) (26)
ESC Core Curriculum for the Cardiologist. (2020) (26)
Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin (2009) (26)
Features of patients with severe mitral stenosis with respect to atrial rhythm. Atrial fibrillation in predominant and tight mitral stenosis. (1992) (26)
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study (2017) (26)
Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis. (2010) (26)
Management of cardiovascular diseases during pregnancy. (2014) (25)
Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus. (1988) (25)
Transseptal implantation of a transcatheter heart valve in a mitral annuloplasty ring to treat mitral repair failure. (2011) (25)
Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition: A Multicenter French Study (2019) (25)
Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. (2015) (25)
Exercise testing and exercise stress echocardiography in asymptomatic aortic valve stenosis (2008) (25)
Transcatheter Aortic Valve Replacement in the Catheterization Laboratory Versus Hybrid Operating Room: Insights From the FRANCE TAVI Registry. (2018) (24)
Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification. (2021) (24)
Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. (2000) (24)
Timing of intervention in asymptomatic patients with valvular heart disease. (2020) (24)
Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry). (2015) (23)
Transcatheter Aortic Valve Replacement to Treat Pure Aortic Regurgitation on Noncalcified Native Valves. (2016) (23)
2020 ESC Guidelines for themanagement of adult congenital heart disease (2021) (23)
Comparison of semiquantitative and quantitative assessment of severity of aortic regurgitation: clinical implications. (2011) (23)
Usefulness of left atrial volume versus diameter to assess thromboembolic risk in mitral stenosis. (2010) (23)
Transvenous mitral valve replacement after failure of surgical ring annuloplasty. (2012) (23)
Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. (2012) (23)
Is the EuroSCORE II reliable to estimate operative mortality among octogenarians? (2017) (22)
Silent T2* cerebral microbleeds (2007) (22)
Degenerative aortic regurgitation. (1991) (22)
First reported human case of native mitral infective endocarditis caused by Streptococcus canis. (2014) (22)
Impact of systematic whole-body 18F-fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study. (2020) (22)
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? (2008) (22)
Radiotherapy-induced mitral stenosis: a three-dimensional perspective. (2010) (22)
Valve Thrombosis After Transcatheter Mitral Valve Replacement. (2016) (22)
Guía de práctica clínica sobre el tratamiento de las valvulopatías = [Guide of clinical practice on the treatment of the valvulopatías] (2007) (21)
Position paper for the evaluation and management of oral status in patients with valvular disease: Groupe de Travail Valvulopathies de la Société Française de Cardiologie, Société Française de Chirurgie Orale, Société Française de Parodontologie et d'Implantologie Orale, Société Française d'Endodont (2017) (20)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over. (2016) (20)
Management of asymptomatic patients with severe non-ischaemic mitral regurgitation. Are practices consistent with guidelines? (2008) (19)
Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. (1994) (19)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes. (2016) (19)
Carotid versus femoral access for transcatheter aortic valve implantation: a propensity score inverse probability weighting study. (2019) (18)
Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. (2013) (18)
Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy (2013) (18)
TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist? (2021) (18)
Common diagnostic flowcharts in infective endocarditis. (2014) (18)
Transarterial Medtronic CoreValve System Implantation for Degenerated Surgically Implanted Aortic Prostheses (2011) (17)
Dismal Outcomes and High Societal Burden of Mitral Valve Regurgitation in France in the Recent Era: A Nationwide Perspective (2020) (17)
Congenital diverticulum of the right ventricle: report of two cases associated with other congenital heart defects. (1989) (17)
Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation (2016) (16)
"Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty. (1998) (16)
Transcatheter aortic valve implantation: our vision of the future. (2012) (16)
Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy. (2016) (16)
Ventricular arrhythmias in aortic valve disease before and after surgery. (1992) (16)
Management of asymptomatic aortic stenosis (2010) (15)
The long-term outcome of balloon valvuloplasty for mitral stenosis (2002) (15)
Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. (2007) (15)
Real-time 3D transoesophageal measurement of the mitral valve area in patients with mitral stenosis. (2011) (15)
Evaluation of mitral valve area by the proximal isovelocity surface area method in mitral stenosis: could it be simplified? (2007) (15)
Echocardiographic Criteria in Selection of Patients for Percutaneous Mitral Commissurotomy (1999) (15)
Linee guida ESC 2015 per il trattamento dell’endocardite infettiva. Task Force per il Trattamento dell’Endocardite Infettiva della Società Europea di Cardiologia (ESC) (2016) (14)
Transoesophageal echocardiography in the assessment of percutaneous mitral commissurotomy. (1991) (14)
[Aortic dissection at 6 months gestation in a women with Marfan's syndrome. Simultaneous Bentall intervention and cesarean section]. (2000) (13)
Characteristics and Outcome of COAPT-Eligible Patients in the MITRA-FR Trial. (2020) (13)
Contemporary Management of Severe Symptomatic Aortic Stenosis. (2021) (13)
Long-term results of mitral valve repair for nonischaemic mitral regurgitation (1991) (13)
A step forward in the evaluation of transcatheter aortic valve implantation. (2010) (13)
The ‘wait for symptoms’ strategy in asymptomatic severe aortic stenosis (2020) (13)
Cardiac cause of hypoxaemia in a kyphoscoliotic patient. (1999) (12)
Presentation and outcomes of mitral valve surgery in France in the recent era: a nationwide perspective (2020) (12)
Management and Outcome of Patients Admitted with Tricuspid Regurgitation in France. (2020) (12)
Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep! (2018) (11)
Transient severe reversible functional mitral regurgitation: a three-dimensional transoesophageal perspective. (2010) (11)
Temporal Trends on Percutaneous Mitral Commissurotomy: 30 Years of Experience (2019) (11)
Aortic root dilatation in young patients with cryptogenic stroke and patent foramen ovale. (2012) (11)
Ethnic disparities in the incidence of infective endocarditis in the Pacific. (2015) (11)
Mitral leaflet separation index: a new method for the evaluation of the severity of mitral stenosis? Usefulness before and after percutaneous mitral commissurotomy. (2007) (11)
The MITRA-HR study: design and rationale of a randomised study of MITRACLIP® transcatheter mitral valve repair in patients with severe primary mitral regurgitation eligible for high-risk surgery. (2019) (11)
Linee guida per il trattamento delle valvulopatie (versione 2012). Task Force congiunta per il Trattamento delle Valvulopatie della Società Europea di Cardiologia (ESC) e dell’Associazione Europea di Chirurgia Cardiotoracica (EACTS) (2013) (11)
Using surgical risk scores in nonsurgically treated infective endocarditis patients. (2019) (10)
The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome (2017) (10)
An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease. (2012) (10)
Percutaneous valve procedures: Present and future (2005) (10)
Towards improved risk scores: the quest for the grail continues. (2013) (10)
Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes (2015) (10)
Cardiac Imaging of Infective Endocarditis, Echo and Beyond (2017) (10)
Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry (2020) (10)
Successful linkage of French large-scale national registry populations to national reimbursement data: Improved data completeness and minimized loss to follow-up. (2020) (10)
Menace d’accouchement prématuré après administration d’adénosine pour la réduction d’une tachycardie supraventriculaire paroxystique à 30 semaines d’aménorrhée : à propos d’un cas (2011) (9)
Eclipsed mitral regurgitation: an unusual cause of acute heart failure (2017) (9)
Valve-in-Valve and Valve-in-Ring Transcatheter Mitral Valve Implantation in Young Women Contemplating Pregnancy (2020) (9)
Position paper of French Interventional Group (GACI) for TAVI in France in 2018. (2018) (9)
Endocardite infectieuse. Épidémiologie, physiopathologie et anatomopathologie (2019) (8)
De FRANCE 2 à FRANCE TAVI : les indications, la technique et les résultats du remplacement valvulaire aortique percutané sont-ils les mêmes ? (2015) (8)
The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update (2018) (8)
A Comparison of Bilateral with Single Internal Mammary Artery Grafts on Postoperative Mediastinal Drainage and Transfusion Requirement (2006) (8)
Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery. (2016) (8)
[From FRANCE 2 to FRANCE TAVI: are indications, technique and results of transcatheter aortic valve replacement the same?]. (2015) (8)
Risk Stratification in Patients With Aortic Stenosis: Pay More Attention to the Right-Side Unit! (2019) (8)
Mitral stenosis still a concern in heart valve diseases. (2008) (8)
Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis. (2016) (8)
[Infective endocarditis. Epidemiology, pathophysiology and histopathology]. (2019) (8)
Comparison of outcomes after one-versus-two transcatheter aortic valve implantation during a same procedure (from the FRANCE2 Registry). (2015) (8)
Post-Procedural Aortic Regurgitation in Balloon-expandable and Self-Expandable TAVR Procedures: Analysis of Predictors and Impact on Long-Term Mortality: Insights from the FRANCE2 Registry (2014) (8)
The TVT Registry: Collaboration Leading to Quality Control. (2017) (8)
Fetal and obstetrical impact of percutaneous balloon mitral commissurotomy during pregnancy. (1994) (8)
Clinical outcomes and direct costs after transcatheter aortic valve implantation in French centres: a longitudinal study of 1332 patients using a national database. (2016) (8)
Diagnostic performance of White Blood Cell SPECT imaging against intra-operative findings in patients with a suspicion of prosthetic valve endocarditis (2021) (7)
Antibiotic prophylaxis of infective endocarditis in patients with predisposing cardiac conditions: French cardiologists' implementation of current guidelines. (2020) (7)
Antegrade transseptal coronary angiography: an alternative technique in severe vascular disease. (1998) (7)
Thromboembolic events early after mitral valve repair: incidence and predictive factors. (2008) (7)
Response to: ‘Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!’ (2018) (7)
Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation. (2017) (7)
Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme (2020) (7)
SILENT T2* CEREBRAL MICROBLEEDS: A POTENTIAL NEW IMAGING CLUE IN INFECTIVE ENDOCARDITIS (2007) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
[Preterm labour after adenosine treatment for paroxysmal supraventricular tachycardia during pregnancy, a case report]. (2011) (7)
Echocardiographic measurement of left atrial volume: Does the method matter? (2015) (7)
Calcifications in Benfluorex-Induced Valve Heart Disease: A Misknown Association (2015) (7)
Long-Term Mortality and Early€Valve€Dysfunction According€to€Anticoagulation Use (2019) (6)
Diagnosis of acute myocarditis with dual source cardiac tomography. (2015) (6)
'Edge to edge' percutaneous mitral valve repair in mitral regurgitation: it can be done but should it be done? (2010) (6)
Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditis. (2020) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
[Recommendations of the French Society of Cardiology concerning the treatment of myocardial infarction after the acute phase. Epidemiology and Prevention Group]. (2001) (6)
Echocardiographic right ventricular function assessment before and after successful percutaneous mitral commissurotomy. (2011) (6)
Trends in aortic valve replacement for aortic stenosis: a French nationwide study. (2021) (6)
Rheumatic Mitral Valve Disease (2009) (6)
Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC) (2021) (6)
Neurologic Complications of Infective Endocarditis: A Joint Model for a Septic Thromboembolism and Inflammatory Small Vessel Disease. (2019) (6)
Percutaneous mitral balloon commissurotomy: a useful and necessary treatment for the western population. (2000) (6)
Les recommandations de l’HAS sur la prise en charge des surdosages, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier (2009) (6)
Lessons from the RE-ALIGN trial. (2014) (6)
Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications. (2016) (6)
Transcatheter aortic valve implantation: a snapshot from the United Kingdom. (2011) (5)
Silent coronary artery disease in asymptomatic patients with severe aortic stenosis and normal exercise testing (2020) (5)
Le rétrécissement mitral (2003) (5)
Retrospective study of anaesthetic management of pregnancy patients with mechanical heart valve prosthesis and anticoagulants. (2017) (5)
Pregnancy-related cardiac complications: a consequence of the burden of rheumatic heart disease in sub-Saharan Africa. (2011) (5)
[Conservative surgery in the treatment of infectious mitral valve insufficiency]. (1994) (5)
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (2022) (5)
Sunday, 26 August 2012 (2012) (5)
New ESC guidelines: aortic disease (2014) (5)
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (2022) (5)
The valve patient and pregnancy (2008) (5)
Impact of previous acute pulmonary oedema after transcatheter aortic valve implantation: insight from French Aortic National CoreValve and Edwards 2 [FRANCE 2]registry. (2015) (5)
Baseline characteristics and outcomes after transcatheter aortic-valve implantation in patients with or without previous balloon aortic valvuloplasty: Insights from the FRANCE 2 registry. (2017) (5)
Severe secondary mitral regurgitation and left ventricular dysfunction: a 'deadly combination' against which the fight is not over! (2015) (5)
[Epidemiology of valvular heart diseases in the adult]. (2009) (5)
Iatrogenic aortic valve perforation assessed using three-dimensional transoesophageal echocardiography. (2011) (5)
Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France. (2021) (5)
High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry (2021) (5)
Transcatheter aortic valve implantation: a treatment we are going to need! (2013) (5)
18F-FDG PET/CT in Infective Endocarditis: New Perspectives for Improving Patient Management. (2019) (4)
Mitral regurgitation (2016) (4)
Quality of life, physical performance and nutritional status in older patients hospitalized in a cardiology department (2020) (4)
Percutaneous Treatment of Aortic Valve Disease: Contemporary Overview and Future Trends. (2017) (4)
Cancer and Infective Endocarditis: Characteristics and Prognostic Impact (2021) (4)
Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement. (2019) (4)
The disproportionate success of the disproportionate concept. (2020) (4)
[Percutaneous mitral commissurotomy during pregnancy]. (1993) (4)
Outcomes of Transcatheter Aortic Valve Implantation in Patients Receiving Chronic Systemic Corticosteroid Treatment. (2020) (4)
Coronary obstruction: a rare but devastating complication during transcatheter aortic valve-in-valve implantation (2018) (4)
Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial. (2020) (4)
Infective endocarditis in French Polynesia: Epidemiology, treatments and outcomes. (2020) (4)
Percutaneous mitral commissurotomy: technique, results, and selection of patients. (2004) (4)
Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation. (2012) (4)
[Left ventricular hypertrophy in patients with hypertension. A comparative study between black Africans and white Europeans]. (1996) (3)
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". (2015) (3)
Monday, 27 August 2012 (2012) (3)
Treatment of mitral regurgitation: from sternotomy to percutaneous approach--a paradigm shift? (2012) (3)
Predictors and Clinical Impact of Thrombosis after Transcatheter Mitral Valve Implantation using Balloon-Expandable Bioprostheses. (2020) (3)
Predicting the outcome of degenerative mitral regurgitation: a step forward but still a long way to go! (2018) (3)
Cardiovascular research in France: Evolution of scientific activities and production over the last decade. (2019) (3)
A nationwide contemporary epidemiological portrait of valvular heart diseases (2017) (3)
Abstract 13765: Impact of Atrial Fibrillation on Clinical Outcomes After Transcatheter Aortic Valve Implantation. Study From the FRANCE 2 Registry (2014) (3)
Understanding risk assessment in cardiac surgery patients. (2010) (3)
[5 years results of percutaneous mitral commissurotomy. Apropos of a series of 606 patients; late results after mitral dilatation]. (1996) (3)
Long-Term Prognosis Value of Paravalvular Leak and Patient–Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry (2022) (3)
Cœur et grossesse (2013) (3)
[Aortic stenosis in the elderly: surgery or TAVI. New European guidelines]. (2013) (3)
Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. (2022) (3)
Transcatheter valves and interventional cardiology. (2011) (3)
Nitrous oxide inhalation for transoesophageal echocardiography: an alternative to benzodiazepine sedation? (2008) (3)
Les accidents thromboemboliques des prothèses valvulaires : incidence, prévention et traitement en 1997 (1997) (3)
[Postpartum myocardial infarction with normal coronary arteries. Apropos of a case]. (1986) (3)
[Cardiac papillary fibroelastoma and stroke during pregnancy: Case report]. (2019) (3)
Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry (2022) (3)
Prevalence of anti-neutrophil cytoplasmic antibodies in infective endocarditis: An analysis of 109 cases (2013) (3)
Atrial Fibrillation and Aortic Stenosis: Complex Interactions Between 2 Diseases. (2020) (3)
Valvular heart disease (2018) (3)
[Value of transesophageal echocardiography in the follow-up of successful percutaneous mitral valvotomy]. (1994) (2)
Infective endocarditis and antibiotic prophylaxis (2015) (2)
098 THE IMPACT OF VALVE SURGERY ON SHORT-AND LONG-TERM MORTALITY IN LEFT-SIDED INFECTIVE ENDOCARDITIS (2009) (2)
Prevalence and Definition of Secondary Mitral Regurgitation (2015) (2)
Introduction and general comments (2018) (2)
Valvular disease: Implications of the new AHA/ACC valvular disease guidelines (2014) (2)
Global threat of rheumatic heart disease: do not forget children! (2022) (2)
Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "the world of AVATAR". (2016) (2)
Current treatment of symptomatic aortic stenosis in elderly patients: Do risk scores really matter after 80 years of age? (2021) (2)
155 Multimodal Assessment of the Aortic Annulus Diameter. Implications for Transcatheter Aortic Valve Implantation (2010) (2)
New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly? (2022) (2)
Towards an increased awareness on infective endocarditis in patients with bloodstream infections: a role for multivariate scores? (2019) (2)
Extracardiac Imaging of Infective Endocarditis (2017) (2)
Are We Right to Believe in the Value of Transcatheter Treatment of Secondary Tricuspid Regurgitation? (2021) (2)
Corrigendum to: Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. (2022) (2)
Aortic stenosis: prognosis and management: Aortic stenosis (2012) (2)
Multiple and Mixed Valvular Heart Diseases (2019) (2)
Real-time 3 D transoesophageal measurement of the mitral valve area in patients with mitral stenosis (2011) (2)
Addressing the Treatment Dilemma in Asymptomatic Aortic Stenosis: The AVATAR Trial. (2019) (2)
Added value of heart valve clinics in the management of asymptomatic aortic stenosis (2023) (2)
Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves. (2019) (2)
Haemophilus parainfluenzae infective endocarditis associated with pelvic abscess: an uncommon complication of endometriosis. (2010) (2)
Impact of Mitral Annular Calcium and Mitral Stenosis on Outcomes After Transcatheter Aortic Valve Implantation. (2021) (2)
Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact? (2012) (2)
Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area (2013) (2)
[Early transesophageal echocardiography after mitral valve replacement. Significance of minor abnormal signals]. (1994) (2)
Les cardiopathies acquises de l’enfant dans les pays en voie de développement (2011) (2)
Les accidents thromboemboliques des prothèses valvulaires des prothèses valvulaires : incidence, prévention et traitement en 1997 (1997) (2)
Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography--are they truly comparable? (2014) (2)
Unmet clinical needs in transcatheter mitral valve interventions in 2014. (2014) (2)
Maladie de Fabry : maladie systémique (2006) (2)
Long-term results of mitral valve repair for non-ischaemic mitral regurgitation. (1991) (2)
Echocardiography in the Patient Undergoing Catheter Balloon Mitral Valvuloplasty: Patient Selection, Hemodynamic Results, Complications, and Long-Term Outcome (2007) (2)
Cancer and Infective endocarditis: diagnosis and prognostic impact. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study (2020) (2)
Épidémiologie des valvulopathies cardiaques de l'adulte : Valvulopathies cardiaques. (2009) (2)
Rétrécissement aortique du sujet âgé : chirurgie ou TAVI. Les nouvelles recommandations européennes (2013) (2)
Fetal and Obstetrical Impact of Percutaneous Balloon Mitral Commissurotomy During Pregnancy (1995) (2)
[Arterial hypertension in black Africans. Clinical and echographic study in 50 patients]. (1996) (2)
The year in cardiology 2015: valvular heart disease. (2016) (2)
Increased Risk of Left Heart Valve Regurgitation Associated with Benfluorex Use in Patients with Diabetes Mellitus. A Multicentre Study (2014) (1)
108: Impact of the method used for aortic annulus measurement on TAVI results - A transesophageal echocardiography and multislice computed tomography comparison (2013) (1)
Community burden of aortic valve disease (2021) (1)
[Bilateral renal embolism during thrombolytic therapy with tissue-type plasminogen activator in a patient with thrombosis of the left ventricle]. (1991) (1)
159 Predictive factors of mid-term mortality after transcatheter aortic valve implantation (2011) (1)
Chapter 21 Valvular Heart Disease (2009) (1)
Erratum: Cohort profile: The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry (European Heart Journal - Quality of Care and Clinical Outcomes (2019) DOI: 10.1093/ehjqcco/qcz018) (2020) (1)
Insuffisance aortique pure de l'adulte (2004) (1)
The TVT Registry: Collaboration Leading to Quality Control. (2017) (1)
Percutaneous Repair for Secondary Mitral Regurgitation. Reply. (2019) (1)
Cardiopathies et grossesse (2007) (1)
Response by Mathieu et al to Letter Regarding Article, "Characterization of 18F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves". (2017) (1)
Genetic diseases of the aorta: aortic diseases related to Marfan syndrome and other genetic abnormalities (2018) (1)
Les outils de XAO dans le cycle de vie de l'automatisation (1989) (1)
0093: Early and late outcomes after trans-catheter aortic valve implantation in patients with previous thoracic irradiation (2016) (1)
[Acquired childhood heart diseases in developing countries]. (2011) (1)
Data on prognostic factors associated with 3-month and 1-year mortality from infective endocarditis (2020) (1)
A Dream Came True (2012) (1)
Response to letter regarding article, "postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry". (2015) (1)
[Recommendations for noncardiac surgery in aortic stenosis]. (2005) (1)
Valve-in-valve vs. repeat surgical aortic valve replacement: a new match but the game is not over! (2020) (1)
NYHA Functional Class in Secondary Mitral Regurgitation: An Old Classification to Evaluate an Innovative Technique. (2020) (1)
Rétrécissement aortique et chirurgie extracardiaque : quelques recommandations (2005) (1)
Rheumatic Heart Disease (2007) (1)
Antibiotics for prevention of endocarditis: time to scale up? Not yet! (2022) (1)
Advances in risk stratification of asymptomatic mitral regurgitation. The quest for optimal timing of surgery continues. (2023) (1)
Cardioprotective Effect of Intracoronary Diltiazem in Myocardial Ischaemia Induced by Percutaneous Transluminal Coronary Angioplasty (1996) (1)
Percutaneous treatment of mitral regurgitation: from feasibility to clinical application? (2011) (1)
THE IMPACT OF THE PRESENCE AND EXTENT OF VALVE CALCIFICATION ON LONG–TERM RESULTS OF PERCUTANEOUS MITRAL COMMISSUROTOMY (2013) (1)
Percutaneous Valvuloplasty in Cardiogenic Shock (2002) (1)
Transcatheter Aortic Valve Replacement in the Catheterization Laboratory Versus Hybrid Operating Room (2018) (1)
Endocarditis caused by Thalassospira sp. (2021) (1)
Mid-term results of percutaneous mitral balloon valvotomy. (1999) (1)
Poor oral health and hygiene habits in patients with infective endocarditis and previously identified predisposing cardiac condition: a prospective cohort study. (2022) (1)
Transcatheter valve-in-valve or valve-in-ring mitral valve implantation in young women contemplating pregnancy (2020) (1)
Rheumatic heart disease and percutaneous mitral commissurotomy across the world. (2009) (1)
Antithrombotic therapy after transcatheter aortic valve implantation (2015) (1)
Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed? (2022) (1)
P5811Real-life management of mitral regurgitations. Lesson from a European survey (2017) (1)
Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis (2022) (1)
The year in cardiovascular medicine 2022: the top 10 papers in valvular heart disease. (2023) (1)
Quality of life after transcatheter aortic valve implantation: the need for more a complete appraisal. (2016) (1)
Comparison of low-dose and standard-dose oral anticoagulant therapy in patients with a mechanical prosthesis. The AREVA multicenter trial (1996) (1)
[ESC guidelines for treatment of cardiovascular disease in pregnancy]. (2012) (1)
A New Match Between Surgery and Transcatheter Aortic Valve Replacement: Fear the Endocarditis. (2019) (1)
[Should mitral valve diseases, without or with few symptoms, be treated surgically?]. (1992) (1)
Is Transesophageal Echocardiography Needed before Hospital Discharge in Patients after Bentall Surgery? (2017) (1)
Transcatheter Mitral Valve Repair in Secondary MR: New Findings and New Challenges. (2019) (1)
Evolution of TAVI patients and techniques over the past decade: The French TAVI registries. (2022) (1)
[Prevention of Infective endocarditis]. (2019) (1)
Management of myocardial infarction: Pay more attention to comorbidities. (2020) (1)
Adverse cardiovascular disease outcomes in patients with aortic sclerosis and mitral annular calcification even when valve function is normal (2021) (1)
Valve thrombosis after transcatheter mitral valve implantation (2021) (1)
Valve weight in aortic stenosis: back to the basics. (2016) (1)
[Isolated carcinoid tumor of the ovary disclosed by tricuspid insufficiency]. (2003) (1)
Prévention de l’endocardite infectieuse (2019) (1)
Considerations on the poor discriminatory power of the FRANCE-2 risk score: Authors' reply (2014) (1)
Mitral Valve Disease (2002) (1)
When chest pain reveals a Fabry disease. (2011) (1)
Tuesday, 28 August 2012 (2012) (1)
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial. (2022) (1)
Atrioventricular valve regurgitation: still a long road ahead (2021) (1)
Prognostic Value of Peak Exercise Systolic Pulmonary Arterial Pressure in Asymptomatic Primary Mitral Valve Regurgitation. (2021) (1)
Euro heart survey Infective endocarditis in Europe: lessons from the (2007) (0)
Aortic diseases (2018) (0)
Valve disease MANAGEMENT OF ISCHAEMIC MITRAL REGURGITATION (2003) (0)
Thromboembolic complications of valvular prostheses : incidence, prevention and treatment in 1997 (1997) (0)
Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial. (2022) (0)
Pregnancy in a Patient With Severe Aortic Stenosis Requiring Unusual Management. (2015) (0)
What are the predictive performance and limitations of the Euroscore II (2013) (0)
142 Impact of coronary artery disease on management of patients referred for transcatheter aortic valve implantation (2011) (0)
Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery (2023) (0)
Percutaneous Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation in a High-Surgical-Risk Patient (2013) (0)
Carcinoid heart disease in patients with midgut neuroendocrine tumours (2023) (0)
Détection en TEP de l’accumulation de 18fluorure de sodium dans les valves de patients avec un rétrécissement aortique calcifié (2012) (0)
0433: Evolution of mitral organic valve disease in Vietnam during last two decades (2015) (0)
Exercise-Induced Severe Mitral Regurgitation in a Patient with Mild Rheumatic Mitral Valve Disease at Rest: a Case Report (2012) (0)
Impact of right ventricular function on the outcomes of transcatheter mitral valve replacement implantation (2023) (0)
IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON VARC-DEFINED OUTCOMES AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: RESULTS FROM THE FRANCE 2 REGISTRY (2014) (0)
[The MitraClip procedure]. (2014) (0)
Aortic valve replacement for aortic stenosis in France – influence of centers' volumes on TAVR adoption rate and outcomes (2022) (0)
Myocardial Work Predicts Outcome in Asymptomatic Severe Aortic Stenosis: Subanalysis of the Randomized AVATAR Trial. (2022) (0)
Eclipsed mitral regurgitation: a new entity responsible for acute heart failure in patients with preserved left ventricular ejection fraction (2017) (0)
Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification (2021) (0)
The need for a continuing awareness of the quality of anticoagulant therapy in patients with mechanical prostheses (2016) (0)
[Combination of theophylline and beta-adrenergic agonists in the treatment of asthma: efficacy and tolerance. Review of the literature]. (1989) (0)
Unexpected findings in anticoagulation management in patients with valvular heart disease after valve surgery (2003) (0)
Isolated tricuspid valve surgery–impact of etiology and clinical presentation on outcomes (2021) (0)
115 Relation between global longitudinal strain in patients with aortic stenosis: relation with severity and symptoms (2011) (0)
157 Stentless Aortic Valve bioprosthesis Dehiscence – A Possible Infective Endocarditis with Atypical Presentation but Serious Consequences (2010) (0)
Erratum to "Evolution of TAVI patients and techniques over the past decade: The French TAVI registries" [Arch. Cardiovasc. Dis. 115 (4) (2022) 206-13]. (2022) (0)
Analysis of disparities in length of hospital stay after transfemoral transcatheter aortic valve implantation: Results from the FRANCE TAVI (French Transcatheter Aortic Valve Implantation) Registry (2019) (0)
The year in cardiovascular medicine 2021: valvular heart disease (2022) (0)
Fabry disease: a systemic disease (2006) (0)
Multimodal imaging assessment of prosthetic mitral valve area after transcatheter mitral valve implantation: A three-dimensional echocardiographic and CT scan study (2023) (0)
Gender specific differences in functional capacity in asymptomatic patients with isolated severe aortic stenosis (2020) (0)
Chapter 8. Mitral Valve Prolapse (2007) (0)
Management during non-cardiac surgery (2018) (0)
0298: Influence of gender on mortality and perioperative outcomes in patients undergoing transcatheter aortic valve implantation: insights from the France 2 registry (2015) (0)
Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (2022) (0)
Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (2022) (0)
Preoperative atrial fibrillation predicts outcome after valve repair for mitral valve prolapse (2014) (0)
Towards a new journal. (2022) (0)
Prophylactic epicardial pacing in tricuspid valve replacement (2021) (0)
Impact of valve surgery in patients with infective endocarditis and neurological complications (2013) (0)
Hospital Resource Use After TAVR (2019) (0)
P6032Temporal trends on percutaneous mitral commissurotomy: 30 years of experience (2018) (0)
[The 2002 recommendations on the prophylaxis of infectious endocarditis]. (2004) (0)
Oral session V: New Insights on left ventricular function in aortic stenosis * Friday 10 December 2010, 08:30-10:00 (2010) (0)
P922Presentation and outcomes of mitral valve surgery in France in the recent era (2019) (0)
Recommandations 2002 sur la prophylaxie de l'endocardite infectieuse (2004) (0)
Cardiac troponin I release after dobutamine stress echocardiography in patients with coronary artery disease (2003) (0)
Role of Calcium Channel Blockers in Reducing Acute Ischaemia and Preventing Restenosis in PTCA (2012) (0)
Comparisons of the new EuroSCORE II with the logistic EuroSCORE and the Society of Thoracic Surgeons score – implications for transcatheter aortic valve implantation (2013) (0)
Anticoagulation in Pregnancy (2014) (0)
230Analysis of disparities in length of hospital stay after transfemoral transcatheter aortic valve implantation: results from the FRANCE TAVI (FRench Transcatheter Aortic Valve Implantation) Registry (2018) (0)
Iconography : When chest pain reveals a Fabry disease (2011) (0)
Heart disease in pregnant women: recent ESC guidelines. (2012) (0)
083 CEREBRAL MICROBLEEDS: A NEW DIAGNOSTIC CLUE IN INFECTIVE ENDOCARDITIS (2009) (0)
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons. (2022) (0)
Wednesday, 29 August 2012 (2012) (0)
Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial (2021) (0)
Real-time 3D transoesophageal echocardiography evaluation of the mitral valve area in patients with mitral stenosis (2011) (0)
Caractéristiques de la fixation du 18FDG par les valves prothétiques cardiaques non infectées (2015) (0)
Les enseignements de l'étude RE-ALIGN (2014) (0)
Clip mitral : quel rôle dans le traitement de l’insuffisance mitrale ? Indications actuelles et perspectives (2014) (0)
Atteinte cardiaque au cours de la maladie Fabry : à propos de 17 observations (2007) (0)
Dix ans après Inoue... Les grands registres de commissurotomie mitrale percutanée (1996) (0)
L’encadrement anticoagulant ou antiagrégant après pose d’endoprothèse TAVI (2022) (0)
L’EuroSCORE II est-il fiable pour évaluer la mortalité des patients de plus de 80 ans ? (2015) (0)
Prise en charge anesthésique de l’accouchement des patientes porteuses d’une bicuspidie aortique. À propos de deux cas consécutifs (2013) (0)
05-45 - CORRÉLATION ENTRE LA SÉVÉRITÉ DU RÉTRÉCISSEMENT MITRAL ET SES DIFFÉRENTS PROFILS HÉMODYNAMIQUES À L’ÉCHOGRAPHIE D’EFFORT (2008) (0)
Perspectives thérapeutiques dans l'insuffisance mitrale (2009) (0)
Valvulopathies et grossesse (2008) (0)
Antibioprophylaxie de l’endocardite infectieuse lors des soins buccodentaires : connaissance des recommandations de bonne pratique. (Étude EPISODE) Enquête nationale auprès des cardiologues français (2015) (0)
Endocardite sur valve aortique insérée par voie transcutanée (TAVI) (2023) (0)
Imagerie fonctionnelle et molculaire de lendocardite infectieuse (2010) (0)
Quelles sont les performances et les limites de l’Euroscore II ? (2013) (0)
Aspirine et AVK chez les porteurs de prothèse valvulaire (2004) (0)
Les analyses de propension : quel crédit leur accorder ? (2008) (0)
Des avancées majeures avec beaucoup d'applications immédiates. (2016) (0)
Intérêt de la scintigraphie aux leucocytes radiomarqués chez les patients avec une suspicion d’endocardite sur prothèse (2012) (0)
Intervention de chirurgie non cardiaque chez un patient ayant un rétrécissement aortique (2018) (0)
Polyvalvulopathies et grossesse (2015) (0)
Traitement des valvulopathies (2001) (0)
État des lieux du rhumatisme articulaire aigu. Quelles avancées dans la prévention ? (2022) (0)
Imagerie et cathétérisme interventionnel valvulaire (2020) (0)
Prophylaxie de l'endocardite À propos des nouvelles recommandations (2010) (0)
Lessons from the RE-ALIGN trial Les enseignements de l ’ étude RE-ALIGN (2014) (0)
Rôle de la scintigraphie aux leucocytes marqués dans la prise en charge des endocardites sur prothèse traitées médicalement (2022) (0)
Les filaments de fibrine: une nouvelle source d'accidents emboliques chez les patients porteurs de prothèses valvulaires? (1994) (0)
JESFC 2023 : Le grand retour de la célébration de la cardiologie française et francophone (2023) (0)
Chapter 57 Acute valve disease and endocarditis (2010) (0)
Recommandations de la Société européenne de cardiologie sur la prise en charge cardiologique de la chirurgie non-cardiaque en présence de cardiopathies (2010) (0)
Prévalence des ANCA au cours de l’endocardite infectieuse : une analyse de 109 cas (2012) (0)
Les procédures interventionnelles de prise en charge de la fuite tricuspide (2017) (0)
Evolution des modèles de prophylaxie de l’endocardite Infectieuse. Point de vue d’experts sur la prise en charge bucco-dentaire des patients valvulaires (2017) (0)
Evolution des modèles de prophylaxie de l’endocardite Infectieuse. Point de vue d’experts sur la prise en charge bucco-dentaire des patients valvulaires (2017) (0)
Mitral balloon valvuloplasty (2018) (0)
Electrocardiographic and echocardiographic abnormalities associated with mitral valve prolapse in patients with Marfan syndrome (2020) (0)
141 Assessment of thromboembolic risk in mitral stenosis. Is left atrial volume superior to diameter (2011) (0)
Faculty Opinions recommendation of Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. (2009) (0)
Aortic prosthetic heart valve obstruction caused by pannus: characteristics and diagnostic strategy, about a 71 patients multicentric study (2017) (0)
[What's new in cardiology]. (2016) (0)
[Long-term results of surgical valvuloplasty for non-ischemic mitral insufficiency. Apropos of 155 cases]. (1991) (0)
Antiphospholipid Autoantibodies and Brain Ischemic Lesions in Infective Endocarditis (2023) (0)
286 Long-term impact of repeat percutaneous mitral commissurotomy on the need for surgery in mitral stenosis. Insights from a series of 912 patients with a 20-year follow-up (2012) (0)
Echocardiographic findings during percutaneous balloon mitral commissurotomy using the stepwise technique (1996) (0)
33 Valvular heart disease (2011) (0)
Abstract 14902: Should Diabetic Status be Part of the Risk Calculation for TAVR Candidates? Insights from the France2 Registry (2012) (0)
P5443The lack of clinical awareness towards the diagnosis of mitral regurgitation. Insights from a European survey (2017) (0)
Transcatheter mitral valve repair for primary and secondary mitral regurgitation: new insights from a nationwide registry (2021) (0)
endocarditis angiography for acute aortic valve infective Preoperative use and safety of coronary (0)
Hemodynamic Complications in Infective Endocarditis (2016) (0)
0007 : Seven-year outcome after TAVI (2016) (0)
HOW TO USE IMAGING Multiple and Mixed Valvular Heart Diseases Pathophysiology , Imaging , and Management Circulation : Cardiovascular Imaging (2018) (0)
Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography. Are they interchangeable (2013) (0)
4.33: Detection of infection after cardiac surgery or after prosthetic vascular graft surgery: usefulness of 99m-Tc HMPAO leucocyte scintigraphy (2007) (0)
0029 : Is the Euroscore II reliable to estimate operative mortality of valvular surgery? (2013) (0)
WHAT ARE THE CURRENT PRACTICES IN ANTITHROMBOTIC THERAPY AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT: A MULTICENTER PATIENT–BASED STUDY (2013) (0)
145: Role of radiolabeled leukocyte scintigraphy in management of patients with a suspicion of prosthetic valve endocarditis (2013) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Cost-Benefit of TAVR: Should Indications Be Expanded? (2015) (0)
State-of-the-art nonvascular interventions: mitral valvuloplasty. (2008) (0)
Acute valve disease and endocarditis (2021) (0)
Role of radiolabeled leukocyte scintigraphy in management of patients with a suspicion of prosthetic valve endocarditis (2014) (0)
193 Progression of aortic valve stenosis is associated with bone remodeling and secondary hyperparathyroidism (2012) (0)
Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis (2022) (0)
Age-related characteristics of infective endocarditis: prospective data from the Euro-Endo registry (2020) (0)
4107Results of Transcatheter Mitral Valve Implantation in Patients with Bioprosthesis Or Annuloplasty Failure Or Mitral Annulus Calcification (2017) (0)
P4538Therapeutic and prognostic impact of comprehensive geriatric assessment in elderly patients with infective endocarditis (2017) (0)
Abstract 18248: Should We Refrain to Perform TAVI Procedures in Patients with a Mitral Regurgitation? Insights from the FRANCE 2 Registry (2012) (0)
Abstract 11378: Preliminary Results of Self-Monitoring of Oral Anticoagulant in French Population Fitted With a Mechanical Heart Valve. The French 4A Study. STIC 2006. (2010) (0)
Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new European definitions, a multicenter French study (2019) (0)
Transseptal transcatheter mitral valve implantation versus redo surgical mitral valve replacement for degenerated mitral bioprostheses (2020) (0)
Impact of cone-beam computed tomography for the identification and management of an oral portal of entry in patients with infective endocarditis. A Delphi study (2021) (0)
Determinants of symptoms in aortic stenosis – Influence of longitudinal strain (2011) (0)
1052 Mitral leaflet separation index: a new method for the evaluation of the severity of mitral stenosis in the setting of percutaneous mitral commissurotomy (2006) (0)
Quality of life, physical performance and nutritional status in older patients hospitalized in cardiology (2018) (0)
0026 : Transfemoral tricuspid valve-in-valve and valve-in-ring implantation using the Edwards SAPIEN XT valve: one-year follow-up (2015) (0)
Iconographies supplémentaires de l'article : Evaluation of mitral stenosis in 2008 (2017) (0)
The year in cardiovascular medicine 2021: valvular heart disease. (2022) (0)
Traitement anticoagulant des patients porteurs de prothèses valvulaires (2004) (0)
[Jejunal perforation by cholesterol embolus: a case treated surgically]. (1992) (0)
Analysis of Length of Hospital Stay after Transfemoral Transcatheter Aortic Valve Implantation: Results from the FRANCE TAVI (FRench Transcatheter Aortic Valve Implantation) Registry (2019) (0)
0374: Seven-year outcome after TAVI (2016) (0)
One-Year Outcome After Cardiac Surgery for Patients With Cancer: An Observational Monocentric Retrospective Study. (2021) (0)
Postoperative Cardiac Troponin I Thresholds Associated With 1-Year Cardiac Mortality After Adult Cardiac Surgery: An Attempt to Link Risk Stratification With Management Stratification in an Observational Study. (2019) (0)
Adenosine for Maternal Supraventricular Tachycardia and Preterm Delivery (2011) (0)
Clinical Research Measurement of the Aortic Annulus Diameter Using Transesophageal Echocardiography and Multislice Computed TomographydAre They Truly Comparable (2014) (0)
[Prognosis after aortic valve replacement for aortic valve stenosis with or without associated coronary lesions]. (1993) (0)
P81 IMPACT OF VALVE SURGERY IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND NEUROLOGICAL COMPLICATIONS (2013) (0)
3071Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study (2018) (0)
INTERVENT IONS FOR STRUCTURAL HEART D ISEASE (2014) (0)
Management during pregnancy (2018) (0)
0028 : What are the predictive performance and limitations of the Euroscore II? (2015) (0)
Club 35 Poster Session Wednesday 11 December: 11/12/2013, 09:30-16:00 * Location: Poster area (2013) (0)
[Dystrophic aortic valve insufficiency]. (1985) (0)
[Anaesthetic management of patients with bicuspid aortic valve for delivery. About two consecutive cases]. (2013) (0)
TRANSCATHETER MITRAL VALVE IMPLANTATION IN HIGH-RISK PATIENTS (2016) (0)
Major adverse cardiovascular events and anaesthetic management in pregnant women with cardiac disease: a retrospective, single-centre study. (2021) (0)
0069 : Early and late outcome after transcatheter aortic valve implantation or surgical aortic valve replacement for high risk patients with aortic stenosis: a monocentric experience (2016) (0)
JESFC 2023: The return to the great celebration of the French-speaking cardiology community (2023) (0)
Edinburgh Research Explorer Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes (2018) (0)
Redo isolated tricuspid valve surgery: prediction of in-hospital mortality using the TRI-SCORE (2022) (0)
Report 2005-2006 Working Group on valvular heart disease (WG 14) (2006) (0)
Iconography : Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation (2017) (0)
P458Impact of Coronary Artery Disease in Patients Undergoing Transcatheter aortic Valve Replacement: Inside The FRANCE-2 Registry (2017) (0)
Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery (2023) (0)
Determinants of adherence to oral hygiene prophylaxis guidelines in patients with previous infective endocarditis. (2023) (0)
139: The impact of the presence and extent of valve calcification on long-term results of percutaneous mitral commissurotomy (2013) (0)
Impact of mitral annulus calcification and associated mitral stenosis on clinical outcomes of transcatheter aortic valve replacement (2021) (0)
Non cardiac surgery and aortic stenosis (2018) (0)
[Mitral stenosis]. (2018) (0)
Hospital Resource Use After TAVR: Clinical and Economic Lessons From Merging Large Databases. (2019) (0)
117 Real-time 3D transoesophageal echocardiography evaluation of the mitral valve area in patients with mitral stenosis (2011) (0)
0079: Respective performances of FDG-PET and radiolabeled leukocyte scintigraphy for the diagnostic of prosthetic valve endocarditis (2015) (0)
174 Pronostic value of brain natriuretic peptide in elderly patients with aortic stenosis (2012) (0)
Incidence, clinical impact and treatment outcomes of valve thrombosis after transcatheter mitral valve implantation (2020) (0)
Follow-up after valve surgery (2006) (0)
0313: Utility of biomarkers in evaluating success of percutaneous mitral valvuloplasty in patients with severe mitral stenosis (2016) (0)
A new risk-score model to predict in-hospital mortality after isolated tricuspid valve surgery for severe tricuspid regurgitation (2022) (0)
[Cirrhosis following hepatitis C, schistosomiasis and pulmonary artery hypertension. Trial with a interferon alpha treatment]. (2000) (0)
Risk calculator to predict 30-day mortality in left-sided infective endocarditis. The EURO-ENDO score (2022) (0)
1213Post-TAVR antithrombotic treatment and one-year survival: insights from the FRANCE TAVI registry (2018) (0)
Club 35 Poster session 2: Thursday 4 December 2014, 08:30-18:00 * Location: Poster area (2014) (0)
Detection of infection after cardiac or prosthetic aortic graft surgery: Accuracy of 99m-Tc-leucocytes scintigraphy (2008) (0)
Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) regist (2022) (0)
A worldwide perspective on the temporal burden and impact of calcific aortic valve disease. (2023) (0)
Percutaneous valve repairs or when the future of cardiology becomes the present (2014) (0)
875Distal color ﬂow jet width measured using transesophageal echocardiography: a new method for quantiﬁcation of mitral regurgitation. ovale: a new factor associated with progression of and left disease. (2004) (0)
SEVEN-YEAR OUTCOME AFTER TAVI (2016) (0)
Unmet needs in valvular heart disease. (2023) (0)
Faculty Opinions recommendation of Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. (2009) (0)
À propos d'un cas de cardiomyopathie hypertrophique sans hypertension artérielle (2009) (0)
160: What are long-term results of percutaneous mitral commissurotomy in patients with few or no symptoms? (2013) (0)
Trends in aortic valve replacement for aortic stenosis: a French nationwide study. (2022) (0)
Mitral valve‐in‐valve and valve‐in‐ring procedures: Midterm outcomes in a French nationwide registry (2022) (0)
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). (2022) (0)
Prosthetic valves (2018) (0)
Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcifications (2013) (0)
Commissural prolapse: a marker of severity for mitral valve repair (1998) (0)
Long‐Term Results After Percutaneous Balloon Mitral Commissurotomy (2000) (0)
Is it possible to perform valve repair for severe mitral regurgitation after percutaneous mitral commissurotomy (1998) (0)
MITRAL valvuloplasty. (1957) (0)
P1784Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era (2019) (0)
Transfemoral implantation of percutaneous heart valves following atrioventricular bioprosthesis and ring annuloplasty failure (2013) (0)
Prophylaxie de l’endocardite infectieuse (2021) (0)
155 Percutaneous aortic balloon valvuloplasty as first-line treatment in high-risk patients scheduled for transcatheter aortic valve implantation (2011) (0)
Contemporary management of aortic stenosis in the elderly. Insights from a recent French registry (2018) (0)
TRANSFEMORAL TRICUSPID VALVE-IN-VALVE AND VALVE-IN-RING IMPLANTATION USING THE EDWARDS SAPIEN XT VALVE: ONE-YEAR FOLLOW-UP (2016) (0)
The impact of transoesophageal echocardiography in elderly patients with infective endocarditis. (2023) (0)
Procedural predictors of Post-TAVR Aortic Regurgitation for Balloon-expendable and Self-expendable devices? Insights from the France 2 registry (2013) (0)
Specific diseases: valvular heart disease (2018) (0)
Tricuspid regurgitation: frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP valvular heart disease II survey (2022) (0)
[Aortic stenosis in the elderly]. (2000) (0)
Epidemiology and physiopathology (2018) (0)
Late results, up to 20 year follow-up, of percutaneous mitral commissurotomy (2013) (0)
[Indications for percutaneous mitral commissurotomy]. (1995) (0)
Impact of chronic obstructive pulmonary disease on one year mortality after transcatheter aortic valve implantation. A substudy from the FRANCE 2 nationwide registry (2013) (0)
190 Surgery of infective endocarditis analyzed within a one-year population-based study (2012) (0)
Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features. (2023) (0)
Incidence and prognostic impact of early major bleeding after transcatheter mitral valve implantation (2023) (0)
Response by Banovic et al to Letter Regarding Article, "Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial". (2022) (0)
132: What are the current practices in antithrombotic therapy after bioprosthetic aortic valve replacement? A multicenter-based study (2013) (0)
Outcomes of transcatheter aortic-valve implantation in patients receiving chronic systemic corticosteroid treatment (2020) (0)
0574: Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis - the COFRASA-GENERAC study (2016) (0)
SAFETY AND EFFICACY OF LOCAL VERSUS GENERAL ANESTHESIA IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION USING A TRANSFEMORAL APPROACH: VARC-DEFINED OUTCOMES IN THE FRANCE 2 REGISTRY (2014) (0)
Aortic Stenosis Prevalence and TAVR (2013) (0)
L’Euroscore II est- il fiable pour évaluer la mortalité en chirurgie valvulaire ? (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernard Iung?

Bernard Iung is affiliated with the following schools:

Bernard Iung's Academic­Influence.com Rankings

Bernard Iung's Degrees

Similar Degrees You Can Earn

Why Is Bernard Iung Influential?

Bernard Iung's Published Works

Published Works

What Schools Are Affiliated With Bernard Iung?

Bernard Iung's AcademicInfluence.com Rankings